Scullion Strategy signs deal for microchip platform, seeking investment
As reported in the 24 October 2017 issue of Animal Pharm by Sian Lazellsian.lazell@informa.com Scullion Strategy Group has signed an exclusive option agreement with Brigham and Women's Hospital (BWH) for a smartphone-based microchip platform for animal fertility. The agreement, effective as of September 27, 2017, gives Scullion the exclusive right to negotiate a worldwide, royalty-bearing license to patent rights for the technology in the field of semen analysis for veterinar
